LeonaBio, Inc.
LONA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001620463
No open-market purchases or sales by LeonaBio, Inc. insiders were filed in the last 90 days; 44 institutions reported holding it in 13F filings for Q2 2026, worth $66.8M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in LeonaBio, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 106
- +1 vs. Q4 2021
- Shares held
- 26.2M
- +10.4K (0.0%) vs. Q4 2021
- Total value
- $353.7M
- +$12.1M (+3.6%) vs. Q4 2021
- New holders
- 18
- 26 more added
- Sold out
- 17
- 35 more reduced
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LONA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 44 | $66.8M |
| Q1 2026 | 40 | $66.0M |
| Q4 2025 | 42 | $46.7M |
| Q3 2025 | 34 | $7.07M |
| Q2 2025 | 51 | $5.30M |
| Q1 2025 | 54 | $5.00M |
| Q4 2024 | 56 | $10.5M |
| Q3 2024 | 58 | $7.19M |
| Q2 2024 | 65 | $58.8M |
| Q1 2024 | 75 | $59.5M |
| Q4 2023 | 65 | $53.2M |
| Q3 2023 | 70 | $43.3M |
| Q2 2023 | 77 | $64.6M |
| Q1 2023 | 83 | $59.5M |
| Q4 2022 | 94 | $73.9M |
| Q3 2022 | 98 | $66.5M |
| Q2 2022 | 98 | $68.0M |
| Q1 2022 | 106 | $353.7M |
| Q4 2021 | 106 | $341.8M |
| Q3 2021 | 93 | $234.0M |
| Q2 2021 | 89 | $253.3M |
| Q1 2021 | 69 | $484.4M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding LeonaBio, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Pathstone Family Office, LLC | 1,629,540 | $22.0M | 0.51% | +187,293+13.0% | Added |
| RTW Investments, LP | 1,906,557 | $25.7M | 0.53% | 00.0% | Unchanged |
| Franklin Resources Inc | 1,967,110 | $26.6M | 0.01% | −112,940−5.4% | Reduced |
| BlackRock Inc. | 2,415,102 | $32.6M | 0.00% | −40,582−1.7% | Reduced |
| Perceptive Advisors LLC | 3,425,916 | $46.3M | 0.96% | 00.0% | Unchanged |
| Silverarc Capital Management, LLC | 10,000 | – | – | +10,000 | New |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −98,661−100.0% | Sold out |
| Jefferies Group LLC | 0 | $0 | 0.00% | −43,000−100.0% | Sold out |
| Pentwater Capital Management LP | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Parametric Portfolio Associates LLC | 0 | $0 | 0.00% | −23,882−100.0% | Sold out |
| NinePointTwo Capital | 0 | $0 | 0.00% | −22,233−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −20,361−100.0% | Sold out |
| Saturna Capital CORP | 0 | $0 | 0.00% | −16,850−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −12,302−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −8,743−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −5,579−100.0% | Sold out |
| Compagnie Lombard Odier SCmA | 0 | $0 | 0.00% | −2,600−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −1,700−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −201−100.0% | Sold out |
| Eagle Bay Advisors LLC | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −89−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −43−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| AlphaCentric Advisors LLC | – | – | – | – | Not filed |